Skip to main content
    C

    CryoCell International Inc (CCEL)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • AMEX

    $4.52
    -0.33 (-6.80%)

    Market Cap: $39.10M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    CryoCell International Inc (CCEL) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect CryoCell International (CCEL) to earn $0.11 per share in the fiscal year ending Nov 30, 2026, on revenue of $30.04M. Over the last 30 days, 1 estimate for the fiscal year ending Nov 30, 2026 was revised up and 0 down. For the fiscal year ending Nov 30, 2027, the EPS consensus is $0.07.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus falls 36.4% and revenue estimates rise 4.9%.

    Fiscal year ending Nov 30, 2026
    $0.11
    EPS consensus, revenue $30.04M
    Fiscal year ending Nov 30, 2027
    $0.07
    EPS consensus, revenue $31.50M
    Next report
    Feb 25, 2027
    Estimated

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Nov 30, 2026$0.11$0.11 to $0.111$30.04M$30.04M to $30.04M1
    Nov 30, 2027$0.07N/A1$31.50M$31.50M to $31.50M1

    Quarterly Estimates

    The EPS consensus falls from $0.05 for the quarter ending Nov 30, 2026 to $0.02 for the quarter ending Feb 28, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Nov 30, 2026$0.05$0.05 to $0.053$7.50M$7.21M to $7.72M3
    Feb 28, 2027$0.02$0.02 to $0.021$7.25M$7.25M to $7.25M1

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Nov 30, 202610
    Fiscal year ending Nov 30, 202710
    Quarter ending Feb 28, 202700

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Nov 30, 2026 has turned from a loss of $0.42 to a profit.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Nov 30, 2026$0.11$0.08$0.08-$0.42-$0.42N/A
    Fiscal year ending Nov 30, 2027$0.07-$0.11-$0.11-$0.11-$0.11N/A

    Frequently Asked Questions About CCEL

    What is the CCEL stock forecast?

    Consensus analyst estimates put CryoCell International's EPS at $0.11 for the fiscal year ending Nov 30, 2026, on revenue of $30.04M.

    What EPS do analysts expect from CCEL next year?

    For the fiscal year ending Nov 30, 2026, the consensus EPS estimate is $0.11, with estimates from $0.11 to $0.11 from 1 analyst. For the fiscal year ending Nov 30, 2027, the consensus EPS estimate is $0.07 from 1 analyst.

    What revenue do analysts expect from CryoCell International next year?

    For the fiscal year ending Nov 30, 2026, the consensus revenue estimate is $30.04M, with estimates from $30.04M to $30.04M. For the fiscal year ending Nov 30, 2027, the consensus revenue estimate is $31.50M, with estimates from $31.50M to $31.50M.

    How many analysts cover CCEL?

    1 analyst estimates EPS for CryoCell International for the fiscal year ending Nov 30, 2026.